A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)
Clinical trial NCT04700280 · TERMINATED
Trial details
- NCT number
- NCT04700280
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2021-10-28
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.